BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 16325694)

  • 1. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial.
    Adam DJ; Beard JD; Cleveland T; Bell J; Bradbury AW; Forbes JF; Fowkes FG; Gillepsie I; Ruckley CV; Raab G; Storkey H;
    Lancet; 2005 Dec; 366(9501):1925-34. PubMed ID: 16325694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial.
    Bradbury AW; Adam DJ; Bell J; Forbes JF; Fowkes FG; Gillespie I; Raab G; Ruckley CV
    Health Technol Assess; 2010 Mar; 14(14):1-210, iii-iv. PubMed ID: 20307380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial.
    Bradbury AW; Moakes CA; Popplewell M; Meecham L; Bate GR; Kelly L; Chetter I; Diamantopoulos A; Ganeshan A; Hall J; Hobbs S; Houlind K; Jarrett H; Lockyer S; Malmstedt J; Patel JV; Patel S; Rashid ST; Saratzis A; Slinn G; Scott DJA; Zayed H; Deeks JJ;
    Lancet; 2023 May; 401(10390):1798-1809. PubMed ID: 37116524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy.
    Bradbury AW; Adam DJ; Bell J; Forbes JF; Fowkes FG; Gillespie I; Ruckley CV; Raab GM;
    J Vasc Surg; 2010 May; 51(5 Suppl):5S-17S. PubMed ID: 20435258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision making.
    Bradbury AW; Adam DJ; Bell J; Forbes JF; Fowkes FG; Gillespie I; Ruckley CV; Raab GM;
    J Vasc Surg; 2010 May; 51(5 Suppl):52S-68S. PubMed ID: 20435262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of Outcomes in Patients with Infrapopliteal Disease Randomised to Vein Bypass or Plain Balloon Angioplasty in the Bypass vs. Angioplasty in Severe Ischaemia of the Leg (BASIL) Trial.
    Popplewell MA; Davies HOB; Narayanswami J; Renton M; Sharp A; Bate G; Patel S; Deeks J; Bradbury AW
    Eur J Vasc Endovasc Surg; 2017 Aug; 54(2):195-201. PubMed ID: 28602580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bypass versus angio plasty in severe ischaemia of the leg - 2 (BASIL-2) trial: study protocol for a randomised controlled trial.
    Popplewell MA; Davies H; Jarrett H; Bate G; Grant M; Patel S; Mehta S; Andronis L; Roberts T; Deeks J; Bradbury A;
    Trials; 2016 Jan; 17():11. PubMed ID: 26739146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis.
    Forbes JF; Adam DJ; Bell J; Fowkes FG; Gillespie I; Raab GM; Ruckley CV; Bradbury AW;
    J Vasc Surg; 2010 May; 51(5 Suppl):43S-51S. PubMed ID: 20435261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment received.
    Bradbury AW; Adam DJ; Bell J; Forbes JF; Fowkes FG; Gillespie I; Ruckley CV; Raab GM;
    J Vasc Surg; 2010 May; 51(5 Suppl):18S-31S. PubMed ID: 20435259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary (2009-2014) clinical outcomes after femoropopliteal bypass surgery for chronic limb threatening ischemia are inferior to those reported in the UK Bypass versus Angioplasty for Severe Ischaemia of the Leg (BASIL) trial (1999-2004).
    Meecham L; Popplewell M; Bate G; Patel S; Bradbury AW
    J Vasc Surg; 2019 Jun; 69(6):1840-1847. PubMed ID: 30852037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Immediate and Long-term Outcomes in Men and Women Undergoing Revascularisation for Chronic Limb Threatening Ischaemia in the Bypass vs. Angioplasty in Severe Ischaemia of the Leg (BASIL-1) Trial.
    Benson RA; Meecham LA; Hewitt CA; Bradbury AW
    Eur J Vasc Endovasc Surg; 2019 Aug; 58(2):224-228. PubMed ID: 31201136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia.
    Conte MS
    J Vasc Surg; 2010 May; 51(5 Suppl):69S-75S. PubMed ID: 20435263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trial.
    Hunt BD; Popplewell MA; Davies H; Meecham L; Jarrett H; Bate G; Grant M; Patel S; Hewitt C; Andronis L; Deeks JJ; Bradbury A;
    Trials; 2017 May; 18(1):224. PubMed ID: 28526046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: what are its implications?
    Bradbury AW
    Semin Vasc Surg; 2009 Dec; 22(4):267-74. PubMed ID: 20006808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparable results with percutaneous transluminal angioplasty and surgical bypass for critical ischaemia of the leg].
    Legemate DA; Reekers JA
    Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1865-7. PubMed ID: 16970006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A description of the severity and extent of disease using the Bollinger angiogram scoring method and the TransAtlantic Inter-Society Consensus II classification.
    Bradbury AW; Adam DJ; Bell J; Forbes JF; Fowkes FG; Gillespie I; Ruckley CV; Raab GM;
    J Vasc Surg; 2010 May; 51(5 Suppl):32S-42S. PubMed ID: 20435260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editor's Choice - A Comparison of Clinical Outcomes Between Primary Bypass and Secondary Bypass After Failed Plain Balloon Angioplasty in the Bypass versus Angioplasty for Severe Ischaemia of the Limb (BASIL) Trial.
    Meecham L; Patel S; Bate GR; Bradbury AW
    Eur J Vasc Endovasc Surg; 2018 May; 55(5):666-671. PubMed ID: 29599067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bypass surgery for chronic lower limb ischaemia.
    Antoniou GA; Georgiadis GS; Antoniou SA; Makar RR; Smout JD; Torella F
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002000. PubMed ID: 28368090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of Clinical Outcomes Following Femoropopliteal Bypass or Plain Balloon Angioplasty with Selective Bare Metal Stenting in the Bypass Versus Angioplasty in Severe Ischaemia of the Limb (BASIL) Trial.
    Meecham L; Bate G; Patel S; Bradbury AW
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1):52-59. PubMed ID: 30786974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia.
    Belch J; Hiatt WR; Baumgartner I; Driver IV; Nikol S; Norgren L; Van Belle E;
    Lancet; 2011 Jun; 377(9781):1929-37. PubMed ID: 21621834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.